CapForce IBD 50 ETF (FFTY) Stock Price & Analysis
CapForce IBD 50 ETF (FFTY) closed at USD 33.48 on Friday, October 23, 2026, up 1.63% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 32.94; the Oct 23, 2026 session ranged USD 33.08–33.6 on volume of 42,975 shares. Market capitalization is —, with a 52-week range of USD 31.61–44.08 (PCX). Source: Nexqual, retrieved October 24, 2026 at 17:53 UTC.
Also available as compact Markdown for AI agents: nexqual.com/FFTY.md
Key facts (FFTY)
- Total return with dividends: 1Y -14.7% vs S&P 500 +13.4%; 5Y -29.5% vs S&P 500 +76.9%.
Total return (dividends reinvested) (FFTY)
| 1Y (from 2025-10-24) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | -14.7% | -29.5% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | -14.8% | -6.8% |
| Volatility (annualized) | 35.5% | 28.4% |
| Max drawdown | -26.9% (Jun 2026→Oct 2026) | -58.9% (Nov 2021→Oct 2023) |
FFTY options: expected move
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 27 | 31.6% | ±7.0% |
| Dec 18, 2026 | 55 | 29.3% | ±9.2% |
| Mar 19, 2027 | 146 | 28.0% | ±14.2% |
| Jun 17, 2027 | 236 | 28.7% | ±18.1% |
30-day implied volatility 25.6% vs 23.2% realized over the last 30 trading days. Put/call ratio (volume) 6.67. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 24, 2026 at 17:53 UTC)
| Price | USD 33.48 |
|---|---|
| Change | ▲ 1.63% (up) |
| Previous Close | USD 32.94 |
| Open | USD 33.05 |
| Day Range | USD 33.08 – 33.6 |
| 52-Week Range | USD 31.61 – 44.08 |
| Volume | 42,975 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (FFTY)
Nexqual's technical model rates FFTY "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 24, 2026 at 17:53 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 41.14 (neutral) |
| vs SMA50 | Below (USD 35.38) |
| MACD | -0.72 (negative) |
Financial Health Score (FFTY)
Nexqual rates CapForce IBD 50 ETF's overall financial health "Mixed" across five dimensions, as of October 24, 2026 at 17:53 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BOUT | CapForce IBD Breakout Opportuni | USD 42.45 | ▲ 0.7% |
| IGV | iShares Expanded Tech-Software | USD 110.59 | ▲ 1.72% |
| MTUM | iShares MSCI USA Momentum Facto | USD 289.45 | ▲ 0.3% |
| IPO | Renaissance IPO ETF | USD 48.36 | ▲ 0.42% |
| IBUY | Amplify Online Retail ETF | USD 70.72 | ▼ 0.97% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 24, 2026 at 17:53 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt